Angiosarcoma presenting as unexplainable unilateral leg pain and purpuric toes
Authors: Genevieve Ho and Dedee F Murrell
Published online: 15 November 2021
An older man presented with increasing pain the in right leg over 3 months, with no relief after femoral artery stenting

An older man presented with increasing pain the in right leg over 3 months, with no relief after femoral artery stenting. He was non‐diabetic and had a normal nerve conduction study. He developed transient tender purpura on the right anterior thigh, then purple‐black nodules isolated to his toes (Figure, A). He had a strongly positive Ro52 titre, suggesting an underlying immunogenic process (autoimmune, infection, neoplastic).1,2 Fluorodeoxyglucose (FDG)‐positron emission tomography (PET)/computed tomography scan revealed innumerable FDG‐avid lesions in the subcutaneous tissues, muscles and bones of the right lower limb, and a focal serosal deposit (Figure, B). Only the toe lesions were appreciated clinically (Figure, B, green arrow). The image shows a focus of left lateralised abdominal activity, possibly representing a small bowel serosal deposit (Figure, B, red arrow). Skin biopsy of a toe lesion revealed angiosarcoma.
Competing interests
No relevant disclosures.
References
- Hervier B, Rimbert M, Colonna F, et al. Clinical significance of anti‐Ro/SSA‐52 kDa antibodies: a retrospective monocentric study. Rheumatology (Oxford) 2009; 48: 964–967.
- Murng SH, Thomas M. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases. J Clin Pathol 2018; 71: 12–19.
Challenges and Opportunities for Strong and Dynamic Foundations in the Australian Cancer Plan
Ashley M. Hopkins, Andrew Rowland, Natansh D. Modi, Ceara Rickard, Mark Haseloff, Norma B. Bulamu, Imogen Ramsey, Niranjan Bidargaddi, Ganessan Kichenadasse, Michael J. Sorich, Kalinda E. Griffiths, Aideen McInerney-Leo, David M. Roder, Raymond J. Chan
Opportunities and Challenges to Achieving the Australian Cancer Plan Goal of World Class Health Systems for Optimal Cancer Care
Carolyn Ee, Ria Joseph, Elise Button, Stacey George, Makala Castelli, David Currow, Prue Cormie, Olivia Farrer, Michael Jefford, Nicolas H. Hart, Chad Y. Han, Deidre D. Morgan, Michael P. Osborn, Candice Oster, Joel Rhee, Anna Ugalde, Eric Yeung, Catherine Paterson
Maximising Cancer Prevention and Early Detection in the Australian Cancer Plan: Where Are We Now and What Should Come Next?
Erin L. Symonds, Billie Bonevski, Richard Edwards, Nathan J. Harrison, Sana Ishaque, Nicole M. Rankin, Sibel Saya, Renee J. Smith, Carolyn Ee
An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres
Sarah Childs, David Ma, Anthony Rodrigues, Jennifer Massey, Rasha Cosman, Venessa Chin, Laila Girgis, James Lynam, Peter Lau, Barbara Withers, Anthony M. Joshua, Ben Tran, Jayesh Desai, Simon J. Harrison, John Moore, Jia Liu
Peritoneal Tuberculosis and Chronic Myeloid Leukaemia: A Case of Hickam's Dictum
Zayn Al-Timimi, Gem Chew, Martin Browne, Christiaan Mostert
From Ambition to Action: Closing Policy, Equity and Implementation Gaps in the Australian Cancer Plan's ‘Enhanced Consumer Experience’
Carla Thamm, Elise Button, Oluwaseyifunmi A. Agbejule, Reegan Knowles, Karen van Gorp, Mark B. Pinkham, Meinir Krishnasamy, Alexandra L. McCarthy, Raymond J. Chan